BIT 2.70% 3.8¢ biotron limited

Maybe after the Doctors Peer review.BIT to treat the HIV in...

  1. 499 Posts.
    lightbulb Created with Sketch. 273
    Maybe after the Doctors Peer review.

    BIT to treat the HIV in macrophages. No other competition. Part of the Cure.

    The question is which Big Pharma will combine with BIT?
    Gilead is in poll position as they combined successfully with Atripla already in Phase ii.
    or
    They can do non-exclusive deals with all BIG Pharma!

    $5 Billion looks pretty lowball.



     










 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.